Mark Basil Swindells
Corporate Officer/Principal at Exscientia AI Ltd.
Profile
Mark Basil Swindells is currently the Chief Strategy Officer at Exscientia AI Ltd.
He previously held the same position at Exscientia Plc.
Mark Basil Swindells active positions
| Companies | Position | Start |
|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Former positions of Mark Basil Swindells
| Companies | Position | End |
|---|---|---|
| EXSCIENTIA PLC | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| Private companies | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Mark Basil Swindells
